Therapeutic Neurotoxin Market, By Type (Botulinum Toxin Type A and Botulinum Toxin Type B), By Application, By End-User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4780
|
Published Date
February 2026
|
Pages
321
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Therapeutic Neurotoxin Market size was valued at US$6,234.65 Million in 2024, expanding at a CAGR of 8.53% from 2025 to 2032.
Therapeutic neurotoxins are biologically derived protein toxins—most commonly purified forms of botulinum toxin—used in controlled medical doses to treat a wide range of neurological, muscular, and glandular disorders. In clinical practice, these neurotoxins work by blocking the release of acetylcholine at neuromuscular junctions, which reduces muscle activation and abnormal nerve activity. This mechanism enables their use in treating conditions such as chronic migraine, spasticity, cervical dystonia, overactive bladder, hyperhidrosis, and certain movement disorders, in addition to popular cosmetic applications. When administered by appropriately trained healthcare professionals, therapeutic neurotoxins produce targeted, reversible effects, offering an efficient treatment option that delivers significant medical benefits and improves patient quality of life. Globally, the therapeutic neurotoxin market was valued at approximately USD6.34billion in 2025, and it is projected to grow to overUSD13billion by 2034, reflecting broad adoption across therapeutic indications and supportive healthcare policies in many countries.
Therapeutic Neurotoxin Market- Market Dynamics
Increasing Demand for Minimally Invasive Aesthetic Procedures
The therapeutic neurotoxin market is experiencing robust growth due to increasing demand for minimally invasive aesthetic treatments. Patients today prefer nonsurgical procedures that offer visible cosmetic improvements with short treatment times, minimal discomfort, no recovery period, and lower health risks. Therapeutic neurotoxins—widely used to reduce facial wrinkles and fine lines—have become a popular aesthetic option because they enable fast, outpatient care that appeals to diverse consumer groups. This trend is supported by greater awareness of facial aesthetics, the influence of social media in shaping beauty standards, and broader acceptance of cosmetic procedures across both younger and older generations. Market expansion is further driven by advances in injection techniques and product formulations that enhance safety and treatment outcomes, encouraging clinics and medical spas to offer repeat treatments. Reflecting this global shift, the market for botulinum toxin used in aesthetic procedures has been growing rapidly, with the global botulinum toxin market projected to reach USD15.7billion by 2030, driven in large part by rising demand for minimally invasive cosmetic applications.
Therapeutic Neurotoxin Market- Segmentation Analysis:
By Type
In 2024, botulinum toxin type A continues to dominate the global market, driven by its well-established clinical effectiveness, safety profile, and versatility across medical and cosmetic applications. The therapeutic use of botulinum toxin type A extends to conditions such as chronic migraine, spasticity, cervical dystonia, overactive bladder, and hyperhidrosis. According to the U.S. Food and Drug Administration (FDA), botulinum toxin type A is among the most frequently approved biologic treatments for these conditions, with hundreds of thousands of patients receiving FDA-approved therapies annually. Its extensive clinical validation and regulatory approval history have built strong confidence among healthcare providers and high acceptance among patients, supporting steady adoption and ongoing demand.
The cosmetic application of botulinum toxin type A also significantly contributes to market growth. Non-surgical aesthetic treatments, including wrinkle reduction and facial contouring, are widely requested by consumers seeking minimally invasive procedures with predictable outcomes. The American Society of Plastic Surgeons (ASPS) reports that over 7 million botulinum toxin procedures were performed in the United States in 2023, making it the most popular non-surgical cosmetic procedure and reflecting the strong patient demand that drives sustained product sales. Overall, the combination of a comprehensive safety record, broad regulatory approvals, and demonstrated clinical efficacy ensures that botulinum toxin type A remains the leading segment in the market. Government oversight and clinical guidelines continue to reinforce proper usage, contributing to consistent adoption in both therapeutic and aesthetic applications. The result is a stable, high-demand market supported by ongoing physician trust and patient preference for established, effective treatments.
Therapeutic Neurotoxin Market- Geographical Insights
North America leads the therapeutic neurotoxin market. The region’s expansion is supported by three primary factors. The United States and neighboring markets benefit from advanced medical infrastructure and relatively high income levels, which sustain both therapeutic and cosmetic use of neurotoxin products. The growing adoption of minimally invasive treatments for conditions such as chronic migraine, spasticity, overactive bladder, and hyperhidrosis has enabled healthcare professionals to apply neurotoxin therapies beyond aesthetic purposes, generating additional revenue streams. Furthermore, ongoing regulatory approvals and product development have expanded clinical indications and treatment options, encouraging greater adoption by both medical professionals and patients.
Globally, the botulinum toxin market—encompassing both therapeutic and aesthetic applications—was valued at approximately USD8.9billion in 2025 and is projected to reach USD15.7billion by 2030, reflecting strong demand supported by regulatory approvals, healthcare policies, and increased use of minimally invasive procedures worldwide. This broad global trend underscores how supportive regulatory environments and adoption initiatives contribute to market growth in North America and beyond.
Therapeutic Neurotoxin Market- Competitive Landscape:
The therapeutic neurotoxin market operates as an oligopoly, with three major established companies dominating global sales, while new entrants, local manufacturers, and biosimilar products are gradually increasing competition and driving innovation in medical applications. The market leaders—AbbVie/Allergan (BOTOX®), Ipsen (DYSPORT®), and Merz (XEOMIN®)—control the majority of branded sales due to their extensive clinical track records, multiple approved indications, and strong brand recognition among healthcare professionals and patients.
Recent Developments:
- In September 2025, Allergan Aesthetics, a subsidiary of AbbVie, launched “The One & Only” campaign for BOTOX® Cosmetic, a national, multichannel marketing initiative promoting self-expression and individuality. BOTOX® Cosmetic became the first and only brand to achieve this milestone, maintaining its status as the top-selling neurotoxin globally, with FDA approval for more aesthetic treatment areas than any other product in its category.
- In April 2025, AbbVie submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), intended for the treatment of moderate to severe glabellar lines.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL THERAPEUTIC NEUROTOXIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- AbbVie Inc.
- Croma-Pharma GmbH
- Ipsen SA
- Daewoong Pharmaceutical Co. Ltd.
- Supernus Pharmaceuticals
- Merz Pharma GmbH & Co KGaA
- Hugel Inc.
- Galderma Inc.
- Medytox Inc.
- Evolus Inc.
- Revance Therapeutics Inc.
GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032
- Botulinum Toxin Type A
- Botulinum Toxin Type B
GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
- Chronic Migraine
- Blepharospasm
- Overactive Bladder
- Spasticity
- Cervical Dystonia
- Others
GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Specialty Clinics
- Others
GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Therapeutic Neurotoxin Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Therapeutic Neurotoxin Market Snippet by Type
2.1.2. Therapeutic Neurotoxin Market Snippet by Application
2.1.3. Therapeutic Neurotoxin Market Snippet by End-User
2.1.4. Therapeutic Neurotoxin Market Snippet by Country
2.1.5. Therapeutic Neurotoxin Market Snippet by Region
2.2. Competitive Insights
3. Therapeutic Neurotoxin Key Market Trends
3.1. Therapeutic Neurotoxin Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Therapeutic Neurotoxin Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Therapeutic Neurotoxin Market Opportunities
3.4. Therapeutic Neurotoxin Market Future Trends
4. Therapeutic Neurotoxin Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Therapeutic Neurotoxin Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Therapeutic Neurotoxin Market Landscape
6.1. Therapeutic Neurotoxin Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Therapeutic Neurotoxin Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
7.1.2. Botulinum Toxin Type A
7.1.3. Botulinum Toxin Type B
8. Therapeutic Neurotoxin Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
8.1.2. Chronic Migraine
8.1.3. Blepharospasm
8.1.4. Overactive Bladder
8.1.5. Spasticity
8.1.6. Cervical Dystonia
8.1.7. Others
9. Therapeutic Neurotoxin Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2024&2032 (%)
9.1.2. Hospitals
9.1.3. Specialty Clinics
9.1.4. Others
10. Therapeutic Neurotoxin Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Therapeutic Neurotoxin Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3. Europe
10.3.1. Overview
10.3.2. Therapeutic Neurotoxin Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Therapeutic Neurotoxin Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Therapeutic Neurotoxin Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Therapeutic Neurotoxin Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Billion)
11. Key Vendor Analysis- Therapeutic Neurotoxin Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. AbbVie Inc.
11.2.2. Croma-Pharma GmbH
11.2.3. Ipsen SA
11.2.4. Daewoong Pharmaceutical Co. Ltd.
11.2.5. Supernus Pharmaceuticals
11.2.6. Merz Pharma GmbH & Co KGaA
11.2.7. Hugel Inc.
11.2.8. Galderma Inc.
11.2.9. Medytox Inc.
11.2.10. Evolus Inc.
11.2.11. Revance Therapeutics Inc.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL THERAPEUTIC NEUROTOXIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- AbbVie Inc.
- Croma-Pharma GmbH
- Ipsen SA
- Daewoong Pharmaceutical Co. Ltd.
- Supernus Pharmaceuticals
- Merz Pharma GmbH & Co KGaA
- Hugel Inc.
- Galderma Inc.
- Medytox Inc.
- Evolus Inc.
- Revance Therapeutics Inc.
GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032
- Botulinum Toxin Type A
- Botulinum Toxin Type B
GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
- Chronic Migraine
- Blepharospasm
- Overactive Bladder
- Spasticity
- Cervical Dystonia
- Others
GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Specialty Clinics
- Others
GLOBAL THERAPEUTIC NEUROTOXIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
